Pictet North America Advisors’s Celgene Corp CELG Stock Holding History

Pictet North America Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14,885	Closed	-$1.48M	–	168
2019 Q3	$1.48M	Sell	14,885 -105	-0.7%	-$9.98K	0.2%	70
2019 Q2	$1.39M	Hold	14,990	–	–	0.2%	68
2019 Q1	$1.41M	Buy	14,990 +685	+5%	+$59.9K	0.21%	65
2018 Q4	$917K	Hold	14,305	–	–	0.08%	85
2018 Q3	$1.28M	Buy	+14,305	New	+$1.26M	0.17%	74
2018 Q1	–	Sell	-17,118	Closed	-$1.79M	–	150
2017 Q4	$1.79M	Buy	+17,118	New	+$1.93M	0.27%	58

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Pictet North America Advisors's CELG Position: Q4 2019 in Review

Pictet North America Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 14,885 shares — an estimated $1.48M sold.

Pictet North America Advisors first reported a position in CELG in Q4 2017 and held it in 6 quarters. The position peaked at $1.79M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Pictet North America Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Pictet North America Advisors sold 14,885 Celgene Corp shares in Q4 2019, an estimated $1.48M.
Pictet North America Advisors first reported a position in Celgene Corp in Q4 2017 and held it in 6 quarters.
Pictet North America Advisors's Celgene Corp position peaked at $1.79M in Q4 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Pictet North America Advisors's 13F filing for Q4 2019, filed 31 Jan 2020.